Annual Retained Earnings
-$394.26 M
-$37.54 M-10.52%
December 31, 2023
Summary
- As of February 7, 2025, ALDX annual retained earnings is -$394.26 million, with the most recent change of -$37.54 million (-10.52%) on December 31, 2023.
- During the last 3 years, ALDX annual retained earnings has fallen by -$157.34 million (-66.41%).
- ALDX annual retained earnings is now -2440.85% below its all-time high of -$15.52 million, reached on December 31, 2011.
Performance
ALDX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$434.30 M
-$15.11 M-3.61%
September 30, 2024
Summary
- As of February 7, 2025, ALDX quarterly retained earnings is -$434.30 million, with the most recent change of -$15.11 million (-3.61%) on September 30, 2024.
- Over the past year, ALDX quarterly retained earnings has dropped by -$44.80 million (-11.50%).
- ALDX quarterly retained earnings is now -961.28% below its all-time high of -$40.92 million, reached on March 31, 2014.
Performance
ALDX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
ALDX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -10.5% | -11.5% |
| 3 y3 years | -66.4% | -55.7% |
| 5 y5 years | -184.6% | -133.2% |
ALDX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -33.8% | at low | -47.4% | at low |
| 5 y | 5-year | -97.8% | at low | -117.8% | at low |
| alltime | all time | -2440.8% | at low | -961.3% | at low |
Aldeyra Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$434.30 M(+3.6%) |
| Jun 2024 | - | -$419.19 M(+4.2%) |
| Mar 2024 | - | -$402.34 M(+2.0%) |
| Dec 2023 | -$394.26 M(+10.5%) | -$394.26 M(+1.2%) |
| Sep 2023 | - | -$389.51 M(+2.1%) |
| Jun 2023 | - | -$381.32 M(+2.4%) |
| Mar 2023 | - | -$372.33 M(+4.4%) |
| Dec 2022 | -$356.72 M(+21.0%) | -$356.72 M(+3.8%) |
| Sep 2022 | - | -$343.81 M(+4.4%) |
| Jun 2022 | - | -$329.26 M(+5.7%) |
| Mar 2022 | - | -$311.48 M(+5.7%) |
| Dec 2021 | -$294.69 M(+24.4%) | -$294.69 M(+5.6%) |
| Sep 2021 | - | -$278.94 M(+6.0%) |
| Jun 2021 | - | -$263.14 M(+6.0%) |
| Mar 2021 | - | -$248.21 M(+4.8%) |
| Dec 2020 | -$236.92 M(+18.8%) | -$236.92 M(+5.0%) |
| Sep 2020 | - | -$225.62 M(+4.1%) |
| Jun 2020 | - | -$216.75 M(+3.6%) |
| Mar 2020 | - | -$209.23 M(+4.9%) |
| Dec 2019 | -$199.36 M(+43.9%) | -$199.36 M(+7.1%) |
| Sep 2019 | - | -$186.20 M(+11.2%) |
| Jun 2019 | - | -$167.49 M(+8.6%) |
| Mar 2019 | - | -$154.16 M(+11.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | -$138.54 M(+39.0%) | -$138.54 M(+8.3%) |
| Sep 2018 | - | -$127.90 M(+9.2%) |
| Jun 2018 | - | -$117.09 M(+8.4%) |
| Mar 2018 | - | -$108.04 M(+8.4%) |
| Dec 2017 | -$99.64 M(+28.9%) | -$99.64 M(+7.5%) |
| Sep 2017 | - | -$92.69 M(+5.7%) |
| Jun 2017 | - | -$87.70 M(+6.4%) |
| Mar 2017 | - | -$82.39 M(+6.6%) |
| Dec 2016 | -$77.30 M(+31.9%) | -$77.30 M(+6.4%) |
| Sep 2016 | - | -$72.65 M(+7.0%) |
| Jun 2016 | - | -$67.87 M(+6.8%) |
| Mar 2016 | - | -$63.57 M(+8.5%) |
| Dec 2015 | -$58.60 M(+26.0%) | -$58.60 M(+8.0%) |
| Sep 2015 | - | -$54.25 M(+6.6%) |
| Jun 2015 | - | -$50.88 M(+4.6%) |
| Mar 2015 | - | -$48.65 M(+4.6%) |
| Dec 2014 | -$46.51 M(+12.6%) | -$46.51 M(+5.5%) |
| Sep 2014 | - | -$44.07 M(+4.8%) |
| Jun 2014 | - | -$42.06 M(+2.8%) |
| Mar 2014 | - | -$40.92 M(-1.0%) |
| Dec 2013 | -$41.32 M(-24.0%) | -$41.32 M(-18.4%) |
| Sep 2013 | - | -$50.62 M(-6.9%) |
| Dec 2012 | -$54.38 M(+250.5%) | -$54.38 M |
| Dec 2011 | -$15.52 M | - |
FAQ
- What is Aldeyra Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics annual retained earnings year-on-year change?
- What is Aldeyra Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics quarterly retained earnings year-on-year change?
What is Aldeyra Therapeutics annual retained earnings?
The current annual retained earnings of ALDX is -$394.26 M
What is the all time high annual retained earnings for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high annual retained earnings is -$15.52 M
What is Aldeyra Therapeutics annual retained earnings year-on-year change?
Over the past year, ALDX annual retained earnings has changed by -$37.54 M (-10.52%)
What is Aldeyra Therapeutics quarterly retained earnings?
The current quarterly retained earnings of ALDX is -$434.30 M
What is the all time high quarterly retained earnings for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high quarterly retained earnings is -$40.92 M
What is Aldeyra Therapeutics quarterly retained earnings year-on-year change?
Over the past year, ALDX quarterly retained earnings has changed by -$44.80 M (-11.50%)